Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
08 2023
Historique:
received: 10 01 2023
revised: 17 04 2023
accepted: 19 04 2023
medline: 17 7 2023
pubmed: 5 5 2023
entrez: 4 5 2023
Statut: ppublish

Résumé

To evaluate the association between baseline severity of visual field (VF) damage and the initial rates of VF progression with quality of life (QOL) outcomes over an extended follow-up in glaucoma. Retrospective cohort study. Both eyes of 167 glaucoma or suspected glaucoma patients were followed for 10.0±0.3 years. The National Eye Institute Visual Function Questionnaire (NEI-VFQ)-25 was performed at the end of the follow-up. Separate linear regression models included the VF parameters of the better eye, the worse eye, and the central and peripheral points of the integrated binocular VF to evaluate the association of baseline and initial rates of change of VF parameters (first half of the follow-up) with NEI-VFQ-25 Rasch-calibrated disability scores over an extended follow-up. All models demonstrated association of worse baseline severity of VF damage with worse subsequent NEI-VFQ-25 scores. Faster rates of decline in VF mean deviation of the better eye and the mean sensitivity of the central and peripheral test locations of the integrated binocular VF were significantly associated with worse subsequent NEI-VFQ-25 scores. VF parameters of the better eye performed better than those of the worse eye (R Baseline severity and initial rates of change of VF damage are associated with QOL outcomes over an extended follow-up. Assessment of longitudinal VF changes, especially in better eye, provides prognostic utility to identify glaucoma patients at a higher risk for developing disease-related disability.

Identifiants

pubmed: 37142176
pii: S0002-9394(23)00187-3
doi: 10.1016/j.ajo.2023.04.017
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

295-305

Subventions

Organisme : NEI NIH HHS
ID : R01 EY034148
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY029058
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY011008
Pays : United States
Organisme : NEI NIH HHS
ID : U10 EY014267
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026574
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY019869
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY027510
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Sasan Moghimi (S)

From the Hamilton Glaucoma Center (S.M., A.K., T.N., L.Z., R.N.W.), Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, USA. Electronic address: sasanimii@yahoo.com.

Alireza Kamalipour (A)

From the Hamilton Glaucoma Center (S.M., A.K., T.N., L.Z., R.N.W.), Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, USA.

Takashi Nishida (T)

From the Hamilton Glaucoma Center (S.M., A.K., T.N., L.Z., R.N.W.), Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, USA.

Linda Zangwill (L)

From the Hamilton Glaucoma Center (S.M., A.K., T.N., L.Z., R.N.W.), Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, USA.

Massimo Fazio (M)

Department of Ophthalmology and Vision Sciences (M.F., C.A.G.), Heersink School of Medicine, Callahan Eye Hospital, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Christopher A Girkin (CA)

Department of Ophthalmology and Vision Sciences (M.F., C.A.G.), Heersink School of Medicine, Callahan Eye Hospital, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Jeffrey M Liebmann (JM)

Bernard and Shirlee Brown Glaucoma Research Laboratory (J.M.L.), Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, USA.

Robert N Weinreb (RN)

From the Hamilton Glaucoma Center (S.M., A.K., T.N., L.Z., R.N.W.), Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH